PATENT CLAIM ANALYSIS

Application Number: 15925517
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "210180"]

Abstract:
This disclosure provides compounds and compositions which may be modulators of MAGL and/or ABHD6 and their use as medicinal agents, processes for their preparation, and pharmaceutical compositions that include disclosed compounds as at least one active agent. The disclosure also provides for method of treating a patient in need thereof, where the patient is suffering from indications such as pain, solid tumor cancer and/or obesity comprising administering a disclosed compound or composition.

Claim (Index 10):
The compound of  claim 8  or  9 , wherein L 3  is selected from the group consisting of a bond, \u2014CH 2 \u2014, \u2014S(O) 2 \u2014, or \u2014C(O)\u2014.

Metadata:
- Claim Count in Document: 10.0
- Percentile: 90.0
- Lexical Diversity: 1.32203
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14599105', '14369982', '15272313', '14902324', '14383076']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8449670410174277
- 35 USC 102 Novelty (BERT): 0.5425420994081952
- Combined Prediction Score: 0.8147245468565045
- Mean Citation Score: 391.818716
- Max Citation Score: 428.7739
- Similarity Product: 250.8098488596916

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test